-
2024-515560-30-00
7
2020-03-05
Advanced-stage, relapsed/refractory cancer
-
2024-511747-25-00
4
2019-12-23
B-cell non-Hodgkin lymphoma (NHL)
-
2024-514088-25-00
5
2019-10-07
Multiple Myeloma
-
2024-514348-95-00
5
2019-06-24
Intrahepatic non-cirrhotic portal hypertension
-
2023-507906-15-00
5
2019-01-30
Relapsing multiple sclerosis (RMS)
-
2023-509976-40-00
5
2018-05-28
Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
-
2024-517489-41-00
5
2017-03-27
High-risk stage III colon cancer
-
2024-513972-16-00
5
2017-01-30
- Resected tumors of sinuses or salivary glands
- Non-operable tumors
-
2024-515846-18-00
7
2016-09-19
Newly diagnosed Diffuse Large B Cell Lymphoma
-
2024-514904-14-00
4
2014-10-08
Patients with metastatic or unresectable locally advanced malignancies
-
2024-518135-10-00
5
2024-10-31
Smokers smoking at least 10 cigarettes/day in the past year
-
2023-507820-22-00
3
2024-05-22
Myasthenia gravis (MG)
-
2023-507771-22-01
5
2025-04-03
Primary Biliary Cholangitis (PBC)
-
2023-506545-27-01
4
2025-01-28
Diabetes mellitus, Type 1
-
2024-511998-30-00
5
2024-10-18
Narcolepsy with Cataplexy (Narcolepsy Type 1)
-
2023-508465-32-00
5
2024-09-03
Narcolepsy with Cataplexy (Narcolepsy Type 1)
-
2023-508413-16-00
4
2024-08-07
Alternating Hemiplegia of Childhood
-
2023-508356-19-00
4
2024-06-25
Pancreatic adenocarcinoma metastatic
-
2023-505893-14-00
5
2024-06-04
Progressive Supranuclear Palsy
-
2023-505413-25-00
3
2024-04-10
Infectious S. aureus endocarditis
-
2023-505499-32-00
5
2024-03-08
Uncontrolled hypertension (uTHN) defined as blood pressure that remain
-
2024-512758-62-00
9
2023-12-18
Patients with newly diagnosed primary central nervous system lymphoma
-
2022-502505-15-00
10
2023-11-09
Leukoencephalopathy
-
2024-513802-77-00
5
2023-08-30
Active non-anterior non-infectious uveitis